Johnson & Johnson: Biotech a shot in the arm for future growth? - Rickey J. White, Jr. | RJW™
29921
post-template-default,single,single-post,postid-29921,single-format-standard,ajax_fade,page_not_loaded,,qode-theme-ver-16.3,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.7,vc_responsive
 

Johnson & Johnson: Biotech a shot in the arm for future growth?

09 Jan Johnson & Johnson: Biotech a shot in the arm for future growth?

Posted at 00:43h in Popular Newsfeed by
0 Likes

Johnson & Johnson is actively shifting its strategy towards biotechnology and antibody-drug conjugates, balancing current revenue protection with future growth.
Source: Entrepreneur.com Lastest News

Tags:
No Comments

Sorry, the comment form is closed at this time.